Publication Date
Publication Topic
6 results found
New Equipment, Expertise and Capacity at Two North American SGS Sites Accelerates Nitrosamine Testing for Customers
We are delighted to announce the expansion of our nitrosamine testing capabilities in two key laboratories, doubling our capacity for nitrosamine testing in North America.
Read more
Our Biosafety Center of Excellence Receives Prestigious Award
We’ve been recognized at Scotland’s Life Sciences Annual Awards 2023.
Read more
New Chemical Testing Lab Opens in Qingdao
A new SGS lab has opened in Qingdao, increasing the company’s chemical testing capabilities in China._x00D_
Read more
Expansion of Glasgow Facility Completed
We have expanded the capacity of our Glasgow testing facility, in a major boost to the development of cell therapies, gene therapies, viral vaccines and other biological medicines.
Read moreFranck Picard, PhD, Joins SGS’s Life Sciences Business
Franck Picard PhD joins SGS as Business Manager of Life Sciences in France and Global Head of Bioanalysis.
Read moreNitrosamine Detection: Meet EMA and FDA Regulations
By April 2020, all marketing authorization holders of medicines containing chemically synthesized APIs must have conducted a risk assessment to evaluate the possibility of nitrosamines being present.
Read more